Human drug discovery is our core focus. We work with companies that bring deep biological expertise in a particular disease area or biological pathway and may even have an RNA target in mind, or those that wish to leverage Nymirum as their holistic partner for broad RNA discovery .
There is a strong relationship between animal and human health, with over 60% of prior and emerging pathogenic diseases being transmissible from animals to humans. We have partnered with leaders in the industry to address outstanding issues in animal health where small molecule targeting of RNA can provide significant value.
The unique application of small molecule RNA targeting has allowed for the potential to impact yield during plant growth, and to develop highly specific herbicides and pesticides while avoiding environmental and human impact.